Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Michael Bookman

General Counsel at Immuneering Corp (IMRX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$3K
Total bought / sold$7K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Oct 2SEC IMRXImmuneering Corp Buy 1,0204,870 held (+26%) $6.83 $7K -42.3%
  • Buy

    General Counsel Michael Bookman bought $7K of IMRX at $6.83 — first open-market purchase in our records; raises the stake by 26%.